# Lyfgenia

NDC: 73554-1111
Generic name: lovotibeglogene autotemcel
Labeler / Manufacturer: Genetix Biotherapeutics Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20231208

FDA application: BLA125788

## Active ingredients

- LOVOTIBEGLOGENE AUTOTEMCEL: 20000000 1/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73554-1111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73554-1111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d1b475e-5781-2bd1-e063-6294a90a7311